Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 2
1991 3
1992 2
1993 3
1996 4
1997 3
1999 2
2000 1
2002 2
2003 3
2007 1
2008 1
2009 1
2011 1
2012 2
2013 3
2014 5
2015 2
2016 2
2017 6
2018 4
2019 3
2021 1
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Cheng Y, Spigel DR, Cho BC, Laktionov KK, Fang J, Chen Y, Zenke Y, Lee KH, Wang Q, Navarro A, Bernabe R, Buchmeier EL, Chang JW, Shiraishi Y, Sezgin Goksu S, Badzio A, Shi A, Daniel DB, Hoa NTT, Zemanova M, Mann H, Gowda H, Jiang H, Senan S; ADRIATIC Investigators. Cheng Y, et al. N Engl J Med. 2024 Oct 10;391(14):1313-1327. doi: 10.1056/NEJMoa2404873. Epub 2024 Sep 13. N Engl J Med. 2024. PMID: 39268857 Clinical Trial.
Maintenance Therapy in Acute Myeloid Leukemia.
Sabakhtarishvili G, Ansari A, Tabbara IA. Sabakhtarishvili G, et al. Among authors: tabbara ia. Am J Clin Oncol. 2025 Jan 1;48(1):38-43. doi: 10.1097/COC.0000000000001140. Epub 2024 Sep 6. Am J Clin Oncol. 2025. PMID: 39238120 Review.
Hematopoietic growth factors.
Tabbara IA, Robinson BE. Tabbara IA, et al. Anticancer Res. 1991 Jan-Feb;11(1):81-90. Anticancer Res. 1991. PMID: 1708221 Review.
Granulocyte colony-stimulating factor.
Tabbara IA. Tabbara IA. South Med J. 1993 Mar;86(3):350-5. doi: 10.1097/00007611-199303000-00020. South Med J. 1993. PMID: 7680827 Review.
PARP Inhibitors in Prostate Cancer.
Grewal K, Grewal K, Tabbara IA. Grewal K, et al. Among authors: tabbara ia. Anticancer Res. 2021 Feb;41(2):551-556. doi: 10.21873/anticanres.14807. Anticancer Res. 2021. PMID: 33517260 Review.
Bruton Tyrosine Kinase Degraders: Current Concepts.
Sabakhtarishvili G, Alshebli M, Bajwa O, Tabbara IA. Sabakhtarishvili G, et al. Among authors: tabbara ia. Am J Clin Oncol. 2025 May 1;48(5):257-261. doi: 10.1097/COC.0000000000001170. Epub 2025 Feb 14. Am J Clin Oncol. 2025. PMID: 39950399 Review.
Emerging therapies in multiple myeloma.
El-Amm J, Tabbara IA. El-Amm J, et al. Among authors: tabbara ia. Am J Clin Oncol. 2015 Jun;38(3):315-21. doi: 10.1097/COC.0b013e3182a4676b. Am J Clin Oncol. 2015. PMID: 23934133 Review.
Erdheim-Chester disease: a comprehensive review.
Abdelfattah AM, Arnaout K, Tabbara IA. Abdelfattah AM, et al. Among authors: tabbara ia. Anticancer Res. 2014 Jul;34(7):3257-61. Anticancer Res. 2014. PMID: 24982329 Review.
Immune-based Therapies for Non-small Cell Lung Cancer.
Rafei H, El-Bahesh E, Finianos A, Nassereddine S, Tabbara I. Rafei H, et al. Among authors: tabbara i. Anticancer Res. 2017 Feb;37(2):377-387. doi: 10.21873/anticanres.11330. Anticancer Res. 2017. PMID: 28179283 Review.
61 results